Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

Chronic myelomonocytic leukemia (CMML) is a rare clonal haematological malignancy bearing characteristics of both myelodysplastic syndromes and myeloproliferative neoplasms. It primarily affects older people (median age at diagnosis ~72 years). There are many challenges encountered in its treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Liapis, Konstantinos, Kotsianidis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710500/
https://www.ncbi.nlm.nih.gov/pubmed/34966690
http://dx.doi.org/10.3389/fonc.2021.801524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710500/
https://www.ncbi.nlm.nih.gov/pubmed/34966690
http://dx.doi.org/10.3389/fonc.2021.801524

Ejemplares similares